Omada Health
OMDA | NASDAQ
$18.04
-$0.69 (-3.68%)
Nov 2, 2026, 2:30 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 87.84M | 78.05M | 75.85M | 68.03M | 61.37M | 54.96M | 47.98M | 45.52M | 41.21M | 35.1M | 32.55M | 32.93M |
Cost of Revenue | 24.05M | 29.36M | 22.18M | 22.96M | 21.19M | 23.06M | 16M | 17.12M | 16.54M | 17.75M | 12.45M | 12.86M |
Gross Profit | 63.79M | 48.69M | 53.66M | 45.07M | 40.18M | 31.9M | 31.98M | 28.39M | 24.67M | 17.35M | 20.1M | 20.07M |
Operating Income | 3.55M | -4.78M | 3.28M | -2.51M | -4.34M | -8.4M | -7.1M | -8.53M | -10.04M | -17.99M | -13.4M | -13.98M |
Interest Income | 1.76M | 1.83M | 1.89M | 2.01M | 863K | 542K | 174K | 17K | 85K | 529K | 979K | 1.43M |
Pretax Income | 5.29M | -2.97M | 5.16M | -3.18M | -5.31M | -9.45M | -8.25M | -9.23M | -10.69M | -18.97M | -13.93M | -13.97M |
Net Income | 5.29M | -2.97M | 5.16M | -3.18M | -5.31M | -9.45M | -8.25M | -9.23M | -10.69M | -18.97M | -13.93M | -13.97M |
Selling & General & Admin | 45.61M | 3.41M | 38.83M | 37.28M | 34.52M | 31.49M | 29.91M | 28.09M | 25.74M | 26.45M | 25.03M | 25.7M |
Research & Development | 14.63M | 739K | 11.55M | 10.3M | 10M | 8.81M | 9.17M | 8.83M | 8.97M | 8.9M | 8.47M | 8.35M |
Other Expenses | n/a | 49.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 60.24M | 53.47M | 50.38M | 47.58M | 44.52M | 40.3M | 39.08M | 36.92M | 34.71M | 35.34M | 33.49M | 34.05M |
Interest Expense | 14K | 18K | 13K | 353K | 1.09M | 1.07M | 1.1M | 1.15M | 1.13M | 1.13M | 1.13M | 1.17M |
Selling & Marketing Expenses | 29.89M | 1.44M | 24.61M | 22.94M | 22.32M | 20.17M | n/a | n/a | n/a | 17.2M | n/a | n/a |
Cost & Expenses | 84.29M | 82.83M | 72.57M | 70.54M | 65.72M | 63.36M | 55.08M | 54.04M | 51.25M | 53.09M | 45.94M | 46.91M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 59.69M | 58.92M | 58.43M | 52.97M | 57.32M | 55.74M | 55.74M | 55.74M | 55.74M | 55.74M | 55.74M | 55.74M |
Shares Outstanding (Diluted) | 63.95M | 58.92M | 58.43M | 57.66M | 57.32M | 55.74M | 55.74M | 55.74M | 55.74M | 55.74M | 55.74M | 55.74M |
EPS (Basic) | 0.09 | -0.05 | 0.09 | -0.06 | -0.09 | -0.17 | -0.15 | -0.17 | -0.19 | -0.34 | -0.25 | -0.25 |
EPS (Diluted) | 0.08 | -0.05 | 0.09 | -0.05 | -0.09 | -0.17 | -0.15 | -0.17 | -0.19 | -0.34 | -0.25 | -0.25 |
EBITDA | 8.4M | -1.44M | 6.62M | -1.82M | -2.87M | -7.04M | -5.87M | -6.85M | -8.39M | -16.71M | -11.67M | -11.69M |
EBIT | 5.31M | -2.95M | 5.17M | -3.18M | -4.22M | -8.37M | -7.15M | -8.08M | -9.56M | -17.84M | -12.8M | -12.8M |
Depreciation & Amortization | 3.09M | 1.51M | 1.45M | 1.36M | 1.35M | 1.33M | 1.28M | 1.23M | 1.17M | 1.13M | 1.12M | 1.11M |
Add to Watchlist
Select watchlists to add or remove OMDA